Europe — EMA
Mirtastad (Mirtazapine)
GNH USA supplies Mirtastad (Mirtazapine), for major depressive disorder, to hospitals, pharmacies and clinics globally. Request a quote for the supply.
Request sourcing
What is Mirtazapine?
Mirtazapine, the active ingredient in Mirtastad, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as a tablet for oral use. It treats major depressive disorder in adult patients. GNH USA supplies Mirtastad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Mirtazapine used for?
Mirtastad, a NaSSA antidepressant, is indicated for conditions within the depressive disorder spectrum.
- Major depressive disorder: reduces depressive symptoms and improves mood in adult patients.
What are the side effects of Mirtazapine?
Mirtastad may cause a range of adverse reactions, which are grouped by frequency.
Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation - Dizziness - Fatigue
Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Severe hypersensitivity reactions (rash, angioedema) - Seizures - Suicidal thoughts or behavior - Hepatotoxicity
What precautions apply to Mirtazapine?
Before initiating therapy, clinicians should consider several safety aspects.
- Assess hepatic function: adjust use in patients with liver impairment. - Monitor for suicidal ideation: especially during early treatment. - Use caution in cardiovascular disease: watch for orthostatic hypotension. - Avoid abrupt discontinuation: taper to reduce withdrawal symptoms. - Adjust dose in renal impairment: consider reduced clearance. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.
What does Mirtazapine interact with?
Mirtastad can interact with other medicines, requiring attention to the interaction strength.
Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other serotonergic agents (e.g., SSRIs, SNRIs): potential serotonin syndrome. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation.
Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine levels. - Carbamazepine: may reduce mirtazapine exposure. - Antihypertensives: additive blood‑pressure lowering effect.
Frequently asked questions
What is Mirtastad used for?+
How does mirtazapine work?+
What is the usual dose of Mirtastad?+
Is Mirtastad safe during pregnancy or breastfeeding?+
How do I order Mirtastad from GNH USA?+
How does Mirtastad compare with other antidepressants?+
What are the storage and handling requirements for Mirtastad?+
How is Mirtastad administered?+
What are the most serious risks associated with Mirtastad?+
Who should not use Mirtastad?+
Product details
Related products

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 30 mg/1
Mirtazapine · 30 mg